Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.
about
Bacterial flagellin-a potent immunomodulatory agent.Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.The Boosting Potential of Bacteria in Cancer Immunotherapy.Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.Large-scale recoding of a bacterial genome by iterative recombineering of synthetic DNA.Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.Immunogenicity and protective efficacy of Vibrio vulnificus flagellin protein FlaB in a wound infection model.Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer.Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella.Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions.Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.Microbial Biogeography Along the Gastrointestinal Tract of a Red PandaCancer Immunotherapy: Priming the Host Immune Response with Live Attenuated
P2860
Q38634734-845F0E79-9125-4C0E-9135-142DA76DDAEDQ38656717-671362CF-7EA8-41E9-868E-B4612E72C8C0Q39267549-685ED99D-985E-4FF3-9BEC-0983D293F416Q39352759-DA3B6705-D5D3-4C59-96DF-59CCAA30BBC5Q40108146-066D4C6C-6004-45E6-BD88-6A40958D2FA4Q40950520-A570F14B-5D77-4196-9EA4-666E6D816DB4Q47195461-12331B89-459E-48FD-B244-1372C3A72F53Q47398449-BE6E6D99-D12D-41B2-B099-3081FAE12197Q47721394-E90B7410-A79D-4DFE-ABBB-67FCAE217290Q50317370-92600D2D-1522-4C53-A42A-7A2A35E3E02AQ50333648-8B5E1816-0EE6-4EFE-B563-F4EA29170A97Q52672798-D23D0B21-E16E-4E46-AC93-FC14A51AC658Q57177059-C4B26892-C75B-4DD8-9158-FBEFDC62D5FDQ57300412-880B5F5A-F4FC-4764-A4DF-D37ABF2F588D
P2860
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@en
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@nl
type
label
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@en
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@nl
prefLabel
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@en
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@nl
P2093
P2860
P1476
Two-step enhanced cancer immun ...... reting heterologous flagellin.
@en
P2093
Hee-Seung Bom
Hyon E Choy
Ik-Joo Chung
Jin Hai Zheng
Joon Haeng Rhee
Jung-Joon Min
Myung Geun Shin
Seol Hee Hong
Seung-Hwan Park
Shee Eun Lee
P2860
P356
10.1126/SCITRANSLMED.AAK9537
P407
P577
2017-02-01T00:00:00Z